Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gen Hiyama

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Cells|May 30, 2019
An In Vitro System for Evaluating Molecular Targeted Drugs Using Lung Patient-Derived Tumor OrganoidsNobuhiko Takahashi, Hirotaka Hoshi, Arisa Higa, et al.
Scientific Reports|December 2, 2015
Lactic acid is a sperm motility inactivation factor in the sperm storage tubulesMei Matsuzaki, Shusei Mizushima, Gen Hiyama, et al.
Oncology Letters|April 12, 2021
Construction of <i>in vitro</i> patient-derived tumor models to evaluate anticancer agents and cancer immunotherapyNobuhiko Takahashi, Arisa Higa, Gen Hiyama, et al.
Oncology Reports|June 20, 2018
Evaluation of anticancer agents using patient-derived tumor organoids characteristically similar to source tissuesHirosumi Tamura, Arisa Higa, Hirotaka Hoshi, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Cells|May 30, 2019
An In Vitro System for Evaluating Molecular Targeted Drugs Using Lung Patient-Derived Tumor OrganoidsNobuhiko Takahashi, Hirotaka Hoshi, Arisa Higa, et al.
Scientific Reports|December 2, 2015
Lactic acid is a sperm motility inactivation factor in the sperm storage tubulesMei Matsuzaki, Shusei Mizushima, Gen Hiyama, et al.
Oncology Letters|April 12, 2021
Construction of <i>in vitro</i> patient-derived tumor models to evaluate anticancer agents and cancer immunotherapyNobuhiko Takahashi, Arisa Higa, Gen Hiyama, et al.
Oncology Reports|June 20, 2018
Evaluation of anticancer agents using patient-derived tumor organoids characteristically similar to source tissuesHirosumi Tamura, Arisa Higa, Hirotaka Hoshi, et al.
Pageof 3